NASDAQ •
Healthcare •
Biotechnology •
Quote as of 07/21/2026 16:00
Company Profile
IndustryBiotechnology
SectorHealthcare
ExchangeNASDAQ
Market Capitalization8.32 mln
Float22.50 mln
Earnings Date08/19/2026
Piotroski F-Score
4
/ 9
Borderline
Relative Strength
5
/ 100
Severely lagging
Debt / Equity
-1.74
Negative equity
ROE
-6,529
Deeply negative
Dividend Yield
0.00%
No dividend
DPS
0.00
No dividend
Business Description
Jupiter Neurosciences is a pharmaceutical company based in Jupiter, Florida, focused on developing treatments for brain and nervous system diseases using a compound called resveratrol. The company currently has five drug candidates in Phase II clinical trials, targeting conditions such as Friedreich's Ataxia, early Alzheimer's disease, Parkinson's disease, and two other rare neurological disorders. Beyond prescription treatments, Jupiter Neurosciences also works with partners to create consumer health products aimed at healthy aging and longevity.